Financhill
Back

Summit Therapeutics 10K Form

Sell
50

SMMT
Summit Therapeutics

Last Price:
20.25
Seasonality Move:
33.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive SMMT News And Ratings

See the #1 stock for the next 7 days that we like better than SMMT

SMMT Financial Statistics

Sales & Book Value

Annual Sales: $705K
Cash Flow: $-33.07M
Price / Cash Flow: 0
Annual Sales: $0.27
Price / Book: 75.16

Profitability

EPS (TTM): -0.19000
Net Income (TTM): $-161.69M
Gross Margin: $760K
Return on Equity: 0%
Return on Assets: 0%

Summit Therapeutics Earnings Forecast

Key Summit Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 15 years for SMMT is 102.29%.
  • The Selling, General & Administrative Expenses for SMMT have been equal to 3,787.23% of Gross Profit Margin.
  • The Interest Expense is -2.68% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Summit Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SMMT
CUSIP: 86627R
Website: smmttx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SMMT Technical Analysis vs Fundamental Analysis

Sell
50
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy or a Sell?